|
0
|
|
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.
(nejm.org)
|
Cohn DM
…
Banerji A
New England Journal of Medicine
2026-06-13
|
#clinical trial
#crispr
#genome editing
#hereditary angioedema
|
|
0
|
|
Atrasentan in patients with IgA nephropathy (ALIGN): final 2.5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Heerspink HJL
…
Barratt J
The Lancet
2026-06-13
|
#clinical trial
#nephropathy
#proteinuria
#kidney disease
#endothelin antagonist
|
|
0
|
|
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.
(nejm.org)
|
Mina R
…
Voorhees PM
New England Journal of Medicine
2026-06-13
|
#antibody
#clinical trial
#immunotherapy
#myeloma
#bispecific
|
|
0
|
|
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
(linkinghub.elsevier.com)
|
Bajaj HS
…
Bartee A
The Lancet
2026-06-13
|
#metabolism
#clinical trial
#diabetes
#obesity
#pharmacology
|
|
0
|
|
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).
(linkinghub.elsevier.com)
|
Neuen BL
…
Agarwal R
The Lancet
2026-06-13
|
#meta-analysis
#clinical trial
#kidney disease
#cardiovascular
#ckd
|